- Home
- / LloydsPharmacy
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LloydsPharmacy financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
£2.2 B
FY, 2018
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2013 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|
| Revenue | 1.8B | 2.0B | 2.2B | 2.2B |
| Revenue growth, % | 6.8% | |||
| Cost of goods sold | 1.3B | 1.5B | 1.6B | 1.7B |
| Gross profit | 517.9M | 539.4M | 535.6M | 499.4M |
| Gross profit margin, % | 29.0% | 26.8% | 24.9% | 23.1% |
| General and administrative expense | 100.9M | 120.0M | ||
| Operating expense total | 514.2M | 567.8M | ||
| Depreciation and amortization | 44.5M | 22.1M | ||
| EBIT | 30.3M | 36.4M | 11.7M | (149.0M) |
| EBIT margin, % | 1.7% | 1.8% | 0.5% | -6.9% |
| Interest income | 1.3M | |||
| Interest expense | 17.1M | 24.9M | ||
| Pre tax profit | 14.5M | 20.0M | (148.8M) | (181.4M) |
| Income tax expense | 2.1M | 7.3M | (15.0M) | (28.9M) |
| Net Income | 12.4M | 12.8M | (133.8M) | (152.5M) |